Clinical Trial Update: Acetyl-leucine in Post-stroke Ataxia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating acetyl-leucine for post-stroke ataxia is currently recruiting for ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Acetyl-leucine (N-acetyl-L-leucine)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Ischemic Stroke | Phase 3 | Status: RECRUITING